Labcorp Holdings (LH) Change in Accured Expenses (2009 - 2026)
Labcorp Holdings' (LH) quarterly Change in Accured Expenses came in at -$24.0 million in Q2 2026, down 410.64% year-over-year from $7.7 million in Q2 2025, and up 12.41% quarter-over-quarter from -$27.4 million in Q1 2026.
Analysis
Labcorp Holdings (LH) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Change in Accured Expenses across 18 years of filings, most recently posting -$24.0 million for Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 410.64% year-over-year to -$24.0 million; the TTM figure through Jun 2026 stood at -$202.3 million (down 61.07% YoY), while the FY2025 annual figure was -$330.3 million, down 193.34% from the prior year.
- Change in Accured Expenses came in at -$24.0 million for Q2 2026 at Labcorp Holdings, up from -$27.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $46.9 million in Q4 2024 to a low of -$212.3 million in Q1 2022.
- Average Change in Accured Expenses over 5 years is -$71.1 million, with a median of -$42.0 million recorded in 2023.
- Year-over-year, Change in Accured Expenses soared 569.0% in 2024 and slumped 731.88% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$33.5 million in 2022, then soared by 70.15% to -$10.0 million in 2023, then soared by 569.0% to $46.9 million in 2024, then sank by 328.78% to -$107.3 million in 2025, then soared by 77.63% to -$24.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$24.0 million in Q2 2026, -$27.4 million in Q1 2026, and -$107.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -39.33 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 142.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -24.00 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 44.29 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 14.68 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 25.08 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -205,000.00 |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 821,000.00 |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 1.01 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.00 Mn |
| Mar 31, 2026 | -27.40 Mn |
| Dec 31, 2025 | -107.30 Mn |
| Sep 30, 2025 | -43.60 Mn |
| Jun 30, 2025 | -4.70 Mn |
| Mar 31, 2025 | -174.70 Mn |
| Dec 31, 2024 | 46.90 Mn |
| Sep 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | -9.50 Mn |
| Mar 31, 2024 | -156.90 Mn |
| Dec 31, 2023 | -10.00 Mn |
| Sep 30, 2023 | -40.40 Mn |
| Jun 30, 2023 | -176.00 Mn |
| Mar 31, 2023 | -96.80 Mn |
| Dec 31, 2022 | -33.50 Mn |
| Sep 30, 2022 | -157.20 Mn |
| Jun 30, 2022 | -59.90 Mn |
| Mar 31, 2022 | -212.30 Mn |
| Dec 31, 2021 | -265.90 Mn |
| Sep 30, 2021 | 65.60 Mn |